Biotech AdvJClub
Rewiring cellular immunotherapy: From CAR evolution to circuit innovations across diseases.
Biotechnology advances · · Review
Chen, Cui + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Programmable immune circuits in CAR-based immunotherapy enable precise regulation and improved discrimination in cancer treatment.
- Why it matters: Current CAR-T therapies face limitations in scalability, manufacturing complexity, and toxicity, restricting their broader clinical application across diseases.
- What they did: The authors review the evolution from linear CAR architectures to programmable immune circuits, highlighting engineering strategies, gene delivery platforms, and design principles across disease contexts.
- The result: This conceptual framework suggests that circuit-based CAR designs can enhance immune activation control, persistence, and specificity, potentially expanding therapeutic effectiveness and safety.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.